NEW YORK (GenomeWeb News) – The National Human Genome Research Institute has awarded HTG Molecular Diagnostics a $1.01 million award to continue development of targeted sequencing products, the Tucson, Ariz.-based company said today.

The one-year Phase II Small Business Innovation Research grant allows HTG to continue work that was carried out under a $599,000 Phase I SBIR grant to the company for the Nuclease Robe Mediated Sequencing Project (HTG EdgeSeq), which seeks to develop targeted sequencing products using HTG's core RNA analysis technology.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.